Morning Overview on MSN
Orcas are learning new scary tricks. Is their intelligence spiking?
Orcas have spent the past few years rewriting their public image from charismatic performers to unpredictable disruptors, ...
Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...
The Hearty Soul on MSN
Universal Vaccine To Treat All Cancers Is Now Enterring Human Trials
Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...
Misinformation isn’t just human. A new study shows how false signals spread across biology, from bacteria to bird flocks.
Some fungi live up to 2,500 years thanks to an internal system that eliminates harmful cells and prevents genetic mutations.
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, unlocking faster diagnoses and new targets for therapy.
An NIH scientist’s maverick approach reveals legal, ethical, moral, scientific and social challenges to developing potentially life-saving vaccines.
Epidermal growth factor receptor (EGFR) is a protein on the surface of your cells that helps them grow. When the gene that codes for EGFR has a mutation, it affects the way this protein works, causing ...
The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results